D. Sanger

发表

Potentiation of prepulse inhibition of the startle reflex in rats: pharmacological evaluation of the procedure as a model for detecting antipsychotic activity

R. Depoortère, G. Perrault, D. Sanger, 1997, Psychopharmacology.

The effects of NMDA antagonists on punished exploration in mice

D. Sanger, D. Joly, 1991, Behavioural pharmacology.

Anxiolytic drugs and the acquisition of conditioned fear in mice

D. Sanger, D. Joly, 2004, Psychopharmacology.

Discriminative stimulus properties of 8-OH-DPAT: relationship to affinity for 5HT1A receptors

D. Sanger, H. Schoemaker, 2005, Psychopharmacology.

The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic

D. Sanger, B. Zivkovic, B. Ẑivković, 2004, Psychopharmacology.

Effects of zolpidem, a new imidazopyridine hypnotic, on the acquisition of conditioned fear in mice

D. Sanger, D. Joly, B. Zivkovic, 2004, Psychopharmacology.

Discriminative stimulus properties of anxiolytic and sedative drugs: pharmacological specificity.

D. Sanger, 1988, Psychopharmacology series.

Further behavioural evidence for the selective sedative action of zolpidem

D. Sanger, B. Zivkovic, B. Ẑivković, 1988, Neuropharmacology.

Investigation of the development of tolerance to the actions of zolpidem and midazolam

D. Sanger, B. Zivkovic, B. Ẑivković, 1987, Neuropharmacology.

Repeated treatment with alpidem, a new anxiolytic, does not induce tolerance or physical dependence

G. Perrault, D. Sanger, B. Zivkovic, 1993, Neuropharmacology.

Target receptors for hypnotics: Relevance to pharmacological profile and therapeutic action

D. Sanger, B. Scatton, S. Z. Langer, 1993, European Neuropsychopharmacology.

Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors

D. Sanger, B. Zivkovic, B. Ẑivković, 1992, Neuropharmacology.

Animal models of anxiety and the development of novel anxiolytic drugs

G. Perrault, D. Sanger, B. Zivkovic, 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Alpidem, an omega-1 receptor-selective partial agonist: a new approach to anxiety treatment

G. Perrault, D. Sanger, S. Z. Langer, 1991, European Neuropsychopharmacology.

Animal Models and Recent Developments in the Search for Novel Anxiolytics

G. Perrault, D. Sanger, B. Zivkovic, 1991 .

Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics.

G. Perrault, D. Sanger, B. Zivkovic, 1990, European journal of pharmacology.

The interaction between zolpidem and beta-CMC: a clue to the identification of receptor sites involved in the sedative effect of zolpidem.

G. Perrault, D. Sanger, B. Zivkovic, 1988, European journal of pharmacology.

Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.

G. Perrault, D. Sanger, K. Lloyd, 1986, The Journal of pharmacology and experimental therapeutics.

The D3 Antagonist PNU-99194A Potentiates the Discriminative Cue Produced by the D3 Agonist 7-OH-DPAT

R. Depoortère, G. Perrault, D. Sanger, 2000, Pharmacology Biochemistry and Behavior.

Effects of D1 dopamine receptor agonists on oral ethanol self-administration in rats: comparison with their efficacy to produce grooming and hyperactivity

G. Perrault, D. Sanger, C. Cohen, 1999, Psychopharmacology.

Preferential involvement of D3 versus D2 dopamine receptors in the effects of dopamine receptor ligands on oral ethanol self-administration in rats

G. Perrault, D. Sanger, C. Cohen, 1998, Psychopharmacology.

The benzodiazepine antagonist CGS 8216 decreases both shocked and unshocked drinking in rats

D. Sanger, 2004, Psychopharmacology.

Rate-Dependence and the Effects of Benzodiazepines1

D. Sanger, D. Blackman, 1981 .

Pharmacological evidence for the involvement of sigma sites in DTG-induced contralateral circling in rats

G. Perrault, D. Sanger, S. Bastianetto, 1995, Neuropharmacology.

Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats.

G. Perrault, D. Sanger, 1995, The Journal of pharmacology and experimental therapeutics.

The effect of repeated nicotine administration on the performance of drug-naive rats in a five-choice serial reaction time task.

D. Sanger, H. Simon, A. Blondel, 1999, Behavioural pharmacology.

Evidence for the involvement of dopamine receptors in ethanol-induced hyperactivity in mice

G. Perrault, D. Sanger, C. Cohen, 1997, Neuropharmacology.

The mouse defense test battery: evaluation of the effects of non-selective and BZ-1 (omega1) selective, benzodiazepine receptor ligands.

G. Perrault, D. Sanger, G. Griebel, 1996, Behavioural pharmacology.

Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands.

G. Perrault, D. Sanger, H. Schoemaker, 1999, Behavioural pharmacology.

Intracranial self-stimulation under a progressive-ratio schedule in rats: effects of strength of stimulation, d-amphetamine, 7-OH-DPAT and haloperidol

R. Depoortère, G. Perrault, D. Sanger, 1999, Psychopharmacology.

Chlordiazepoxide-induced hyperphagia in rats: lack of effect of GABA agonists and antagonists

D. Sanger, 2004, Psychopharmacology.

GABA and the behavioral effects of anxiolytic drugs.

D. Sanger, 1985, Life sciences.

The preclinical pharmacologic profile of tiapride

G. Perrault, D. Sanger, H. Schoemaker, 2001, European Psychiatry.

The Pharmacological Properties of Tiapride

G. Perrault, D. Sanger, H. Schoemaker, 1998 .

Endorphinergic Mechanisms in Food, Salt and Water Intake: An Overview

S. Cooper, D. Sanger, 1984, Appetite.

Effects of d-amphetamine on the behavior of pigeons maintained by a second-order schedule of reinforcement.

D. Sanger, N. Bond, D. Blackman, 1975, The Journal of pharmacology and experimental therapeutics.

Further investigation of the stimulus properties of chlordiazepoxide and zolpidem. Agonism and antagonism by two novel benzodiazepines

D. Sanger, 2004, Psychopharmacology.

Reduction of Oral Ethanol Self-Administration in Rats by Monoamine Oxidase Inhibitors

G. Perrault, D. Sanger, C. Cohen, 1999, Pharmacology Biochemistry and Behavior.

Buspirone, gepirone and ipsapirone disrupt both active and passive avoidance responding in rats

D. Sanger, D. Joly, M. LePichon, 1989, Behavioural pharmacology.

Discriminative stimulus effects of the alpha 2-adrenoceptor antagonist idazoxan.

D. Sanger, 1989, Psychopharmacology.

Subtype-selective benzodiazepine receptor ligands

G. Perrault, D. Sanger, G. Griebel, 2000 .

Behavioural profiles of the reversible monoamine-oxidase-A inhibitors befloxatone and moclobemide in an experimental model for screening anxiolytic and anti-panic drugs

G. Perrault, D. Sanger, G. Griebel, 1997, Psychopharmacology.

Discriminative Stimulus Effects of Drugs Acting at GABAA Receptors Differential Profiles and Receptor Selectivity

G. Perrault, D. Sanger, H. Schoemaker, 1999, Pharmacology Biochemistry and Behavior.

The anorectic action of naloxone is attenuated by adaptation to a food-deprivation schedule

D. Sanger, P. S. McCarthy, 1982, Psychopharmacology.

Behavioural effects of the α2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine

D. Sanger, 2004, Psychopharmacology.

Discriminative stimulus effects of the α2-adrenoceptor antagonist idazoxan

D. Sanger, 1989, Psychopharmacology.

The α2-adrenoceptor antagonists idazoxan and yohimbine increase rates of DRL responding in rats

D. Sanger, 2004, Psychopharmacology.

Investigation of the actions of the benzodiazepine antagonists Ro 15-1788 and CGS 8216 using the schedule-controlled behavior of rats

D. Sanger, 1986, Pharmacology Biochemistry and Behavior.

Benzodiazepine (ω) receptor partial agonists and the acquisition of conditioned fear in mice

G. Perrault, D. Sanger, D. Joly, 1995, Psychopharmacology.

New perspectives for the treatment of disorders of sleep and arousal.

D. Sanger, B. Scatton, C. Soubrane, 2007, Annales pharmaceutiques francaises.

Discriminative stimulus effects of alpidem, a new imidazopyridine anxiolytic

D. Sanger, B. Zivkovic, B. Ẑivković, 2005, Psychopharmacology.

Endorphinergic mechanisms in the control of food and water intake

D. Sanger, 1981, Appetite.

Contemporary Research in Behavioral Pharmacology

D. Sanger, D. Blackman, 1978 .

Recent developments in the behavioral pharmacology of benzodiazepine (ω) receptors: Evidence for the functional significance of receptor subtypes

G. Perrault, D. Sanger, C. Cohen, 1994, Neuroscience & Biobehavioral Reviews.

Pharmacological and Behavioral Profile of Alpidem as an Anxiolytic

G. Perrault, D. Sanger, K. Lloyd, 1990, Pharmacopsychiatry.

The Pharmacology and Mechanism of Action of Zolpidem.

D. Sanger, H. Depoortere, 1998, CNS drug reviews.

The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure

D. J. Sanger, E. Morel, G. Perrault, 1987, Physiology & Behavior.

Mild traumatic lesion of the right parietal cortex in the rat: Characterisation of a conditioned freezing deficit and its reversal by dizocilpine

D. Sanger, P. Moser, S. Hogg, 1998, Behavioural Brain Research.

The effects of new hypnotic drugs in rats trained to discriminate ethanol

D. Sanger, 1997, Behavioural pharmacology.

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents Comparison with diazepam and buspirone

G. Perrault, D. Sanger, G. Griebel, 1998, Psychopharmacology.

Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine–oxidase activity and monoamine levels

G. Perrault, D. Sanger, G. Griebel, 1998, Neuropharmacology.

Effects of Drugs on Schedule-Controlled Behavior

D. Sanger, 1987 .

Learned taste aversion to saccharin produced by orally consumed d-amphetamine

D. Sanger, A. Greenshaw, J. D. Mercer, 1980, Pharmacology Biochemistry and Behavior.

Animal Models of Anxiety and the Screening and Development of Novel Anxiolytic Drugs

D. Sanger, 1991 .

DTG-induced circling behaviour in rats may involve the interaction between σ sites and nigro-striatal dopaminergic pathways

G. Perrault, D. Sanger, L. Rouquier, 1995, Neuropharmacology.

Pharmacological studies on synthetic flavonoids: comparison with diazepam

G. Perrault, D. Sanger, H. Schoemaker, 1999, Neuropharmacology.

Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice

G. Perrault, D. Sanger, G. Griebel, 2000, Psychopharmacology.

Effects of buspirone and related compounds on suppressed operant responding in rats.

D. Sanger, 1990, The Journal of pharmacology and experimental therapeutics.

NMDA antagonists disrupt timing behaviour in rats

D. Sanger, 1992, Behavioural pharmacology.

The effects of opiate antagonists on food intake are stereospecific

D. Sanger, G. Metcalf, P. S. McCarthy, 1981, Neuropharmacology.

Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.

R. Depoortère, G. Perrault, D. Sanger, 2000, European journal of pharmacology.

Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists

R. Depoortère, G. Perrault, D. Sanger, 1999, Neuropharmacology.

Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice

R. Depoortère, G. Perrault, D. Sanger, 1999, Neuropharmacology.

Effects of NMDA receptor antagonists and sigma ligands on the acquisition of conditioned fear in mice

D. Sanger, D. Joly, 2005, Psychopharmacology.

Memantine has phencyclidine-like but not cocaine-like discriminative stimulus effects in rats.

D. Sanger, P. Terry, J. Katz, 1992, Behavioural pharmacology.

The Pharmacology and Mechanisms of Action of New Generation, Non-Benzodiazepine Hypnotic Agents

D. Sanger, 2004, CNS Drugs.

Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem.

G. Perrault, D. Sanger, E. Morel, 1996, European journal of pharmacology.

Differential effects of morphine on food and water intake in food deprived and freely-feeding rats

D. Sanger, P. S. McCarthy, 2004, Psychopharmacology.

Discriminative stimulus effects of apomorphine and 7-OH-DPAT: a potential role for dopamine D3 receptors

R. Depoortère, G. Perrault, D. Sanger, 1997, Psychopharmacology.

Some, but not all, antipsychotic drugs potentiate a low level of prepulse inhibition shown by rats of the Wistar strain

R. Depoortère, D. Sanger, Gh. Perrault, 1997, Behavioural pharmacology.

The pharmacology and abuse potential of buprenorphine: A new antagonist analgesic.

D. Sanger, J. Lewis, M. J. Rance, 1983 .

Lithium and α-methyl-p-tyrosine prevent “manic” activity in rodents

D. Sanger, M. Tomkiewicz, D. U'prichard, 1974, Psychopharmacologia.

The search for novel antipsychotics: pharmacological and molecular targets

D. Sanger, 2004, Expert opinion on therapeutic targets.

Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.

D J Sanger, R. Depoortère, G. Perrault, 1997, The Journal of pharmacology and experimental therapeutics.

Pharmacological and molecular targets in the search for novel antipsychotics

D. Sanger, B. Scatton, 2000, Behavioural pharmacology.

Performance of a passive avoidance response is disrupted by compounds acting at 5HT1A receptors

D. Sanger, D. Joly, 1989, Behavioural Pharmacology.

The effects of fenfluramine on schedule-induced drinking in rats

D. Sanger, 1979, Pharmacology Biochemistry and Behavior.

Discriminative stimulus effects of ω (BZ) receptor ligands: correlation with in vivo inhibition of [3H]-flumazenil binding in different regions of the rat central nervous system

D. Sanger, J. Benavides, 2005, Psychopharmacology.

Characterization of the discriminative stimulus produced by the dopamine antagonist tiapride.

G. Perrault, D. Sanger, C. Cohen, 1997, The Journal of pharmacology and experimental therapeutics.

Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats.

D. Sanger, K. Nicholson, R. Balster, 1994, Drug and alcohol dependence.

Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-d-aspartate receptors?

D. Sanger, A. Jackson, 2006, Psychopharmacology.

The discriminative stimulus effects of MK-801: Generalization to other N-methyl-D-aspartate receptor antagonists

D. Sanger, B. Ẑivković, 1989, Journal of psychopharmacology.

Conditioned taste aversions induced by phencyclidine and other antagonists of N-methyl-d-aspartate

D. Sanger, A. Jackson, 1989, Neuropharmacology.

Discriminative stimulus properties of chlordiazepoxide and zolpidem. Agonist and antagonist effects of CGS 9896 and ZK 91296

D. Sanger, B. Ẑivković, 1987, Neuropharmacology.

The anorectic properties of opiate antagonists

D. Sanger, C. Smith, C.F.C. Smith, 1984 .

Anxiogenic properties of beta-CCE and FG 7142: a review of promises and pitfalls

D. Sanger, P. Soubrié, M. Thiébot, 2004, Psychopharmacology.

Tolerance, cross-tolerance and dependence measured by operant responding in rats treated with triazolam via osmotic pumps

D. Sanger, C. Cohen, 1994, Psychopharmacology.

Orphanin FQ, a novel neuropeptide with anti-stress-like activity

G. Perrault, D. Sanger, G. Griebel, 1999, Brain Research.

Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem.

G. Perrault, D. Sanger, E. Morel, 1992, The Journal of pharmacology and experimental therapeutics.

Rate-dependent effects of drugs: A review of the literature

D. Sanger, D. Blackman, 1976, Pharmacology Biochemistry and Behavior.

The Effects of Drugs on Adjunctive Behavior

D. Sanger, D. Blackman, 1978 .

Operant Behavior and the Effects of Centrally Acting Drugs

D. Sanger, D. Blackman, 1989 .

New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (ω) receptor subtypes

G. Perrault, D. Sanger, H. Schoemaker, 1999, Psychopharmacology.

Further evidence for differences between non-selective and BZ-1 (ω1) Selective, benzodiazepine receptor ligands in murine models of “state” and “trait” Anxiety

G. Perrault, D. Sanger, G. Griebel, 1996, Neuropharmacology.

Nicotine and schedule-induced drinking in rats

D. Sanger, 1978, Pharmacology Biochemistry and Behavior.

The effects of d-amphetamine and scopolamine on drinking induced by a multiple schedule

D. Sanger, 1978, Psychopharmacology.

Effects of d-amphetamine on temporal and spatial discrimination in rats

D. Sanger, 1978, Psychopharmacology.

Effects of chlordiazepoxide, ripazepam and d-amphetamine on conditioned acceleration of timing behaviour in rats

D. Sanger, D. Blackman, 1976, Psychopharmacology.

Schedule-Dependent Effects Of Chlordiazepoxide On Operant Behavior In Rats

D. Sanger, D. Blackman, 1976 .

Behavioural genetics and its relevance to psychiatry.

D. Sanger, P. Willner, J. Bergman, 2008, Behavioural pharmacology.

Applications of behavioural pharmacology in drug discovery.

D. Sanger, P. Willner, J. Bergman, 2003, Behavioural pharmacology.

The effects of compounds varying in selectivity as 5-HT1A receptor antagonists in three rat models of anxiety

G. Perrault, D. Sanger, G. Griebel, 2000, Neuropharmacology.

Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9 10 of the cerebellum: A D3 receptor mediated effect?

G. Perrault, D. Sanger, D. Boulay, 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

CCK receptor antagonists in animal models of anxiety: comparison between exploration tests, conflict procedures and a model based on defensive behaviours

G. Perrault, D. Sanger, G. Griebel, 1997, Behavioural pharmacology.

GABAB Receptors and Antidepressant Drugs

D. Sanger, K. Lloyd, P. Pichat, 1989 .

Quantitative motor assessment in FALS mice: a longitudinal study

D. Sanger, B. Scatton, P. Barnéoud, 1997, Neuroreport.

Increased rates of punished responding produced by buspirone-like compounds in rats.

D. Sanger, 1992, The Journal of pharmacology and experimental therapeutics.

Behavioral effects of nonbenzodiazepine anxiolytic drugs: a comparison of CGS 9896 and zopiclone with chlordiazepoxide.

D. Sanger, D. Joly, B. Ẑivković, 1985, The Journal of pharmacology and experimental therapeutics.

Risk Assessment Behaviour: Evaluation of Utility in the Study of 5-HT-Related Drugs in the Rat Elevated Plus-Maze Test

G. Perrault, D. Sanger, G. Griebel, 1997, Pharmacology Biochemistry and Behavior.

Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice

G. Perrault, D. Sanger, E. Morel, 1992, Pharmacology Biochemistry and Behavior.

A comparison of the effects of opiate antagonists on operant and ingestive behavior

D. Sanger, P. S. McCarthy, 1982, Pharmacology Biochemistry and Behavior.

Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT1A receptor antagonists

G. Perrault, D. Sanger, G. Griebel, 1999, Psychopharmacology.

Mild traumatic lesion of the right parietal cortex of the rat: Selective behavioural deficits in the absence of neurological impairment

Sandy Hogg, D. Sanger, P. Moser, 1998, Behavioural Brain Research.

Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile.

D. Sanger, K. Lloyd, G. Bartholini, 1987, The Journal of pharmacology and experimental therapeutics.

Genetic differences in the mouse defense test battery

G. Perrault, D. Sanger, G. Griebel, 1997 .

The effects of d-amphetamine on the temporal control of operant responding in rats during a preshock stimulus.

D. Sanger, D. Blackman, D J Sanger, 1976, Journal of the experimental analysis of behavior.

Effects of dihydropyridine Ca2+ channel blockers on the discriminative stimulus and the motor impairing effects of (+/-)-Bay K 8644.

G. Perrault, D. Sanger, C. Cohen, 1997, European journal of pharmacology.

Schedule-induced drinking of chlordiazepoxide solutions by rats

D. Sanger, 1977, Pharmacology Biochemistry and Behavior.

Effects of diazepam and ripazepam on two measures of adjunctive drinking in rats

D. Sanger, D. Blackman, 1976, Pharmacology Biochemistry and Behavior.

Rate-dependent effects of drugs on the variable-interval behavior of rats.

D. Sanger, D. Blackman, 1975, The Journal of pharmacology and experimental therapeutics.

Increased food and water intake produced in rats by opiate receptor agonists

D. Sanger, P. S. McCarthy, 2004, Psychopharmacology.

Anorectic actions of the opiate antagonist naloxone.

D. Sanger, P. Dettmar, A. G. Lynn, 1981, Neuropharmacology.

5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.

D J Sanger, D. Sanger, P C Moser, 1999, European journal of pharmacology.

Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents

G. Perrault, D. Sanger, G. Griebel, 1998, Journal of psychopharmacology.

Inhibition of scopolamine-induced stimulation of Y-maze activity by alpha-methyl-p-tyrosine and by lithium.

D. Sanger, H. Steinberg, 1974, European journal of pharmacology.

Scopolamine and adjunctive drinking in rats

D. Sanger, 1976, Psychopharmacology.

Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies

D. Sanger, Anne Blondel, David J. Sanger, 2000, Psychopharmacology.

A Comparative Study of the Effects of Selective and Non-Selective 5-HT2 Receptor Subtype Antagonists in Rat and Mouse Models of Anxiety

G. Perrault, D. Sanger, G. Griebel, 1997, Neuropharmacology.

The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands

G. Perrault, D. Sanger, G. Griebel, 1996, Psychopharmacology.

Behavioral Effects of Acute and Chronic Fluoxetine in Wistar–Kyoto Rats

G. Perrault, D. Sanger, G. Griebel, 1999, Physiology & Behavior.

Prepulse inhibition of the startle reflex in rats: effects of compounds acting at various sites on the NMDA receptor complex.

R. Depoortère, G. Perrault, D. Sanger, 1999, Behavioural pharmacology.

Evidence for a role for dopamine D3 receptors in the effects of dopamine agonists on operant behaviour in rats.

R. Depoortère, G. Perrault, D. Sanger, 1996, Behavioural pharmacology.

Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine

R. Depoortère, G. Perrault, D. Sanger, 1996, Psychopharmacology.

Behavioural effects of novel benzodiazepine (ω) receptor agonists and partial agonists: increases in punished responding and antagonism of the pentylenetetrazole cue

D. Sanger, 1995, Behavioural Pharmacology.

Behavioural Pharmacology of Dopamine D2 and D3 Receptors: Use of the Knock-out Mice Approach

R. Depoortère, G. Perrault, D. Sanger, 2002 .

The effects of fluoxetine and zimeldine on the behavior of olfactory bulbectomized rats

D. Sanger, D. Joly, 1986, Pharmacology Biochemistry and Behavior.

Differences in Anxiolytic-Like Profile of Two Novel Nonbenzodiazepine BZ (ϖ) Receptor Agonists on Defensive Behaviors of Mice

G. Perrault, D. Sanger, G. Griebel, 1999, Pharmacology Biochemistry and Behavior.

Amisulpride: from animal pharmacology to therapeutic action

G. Perrault, D. Sanger, H. Schoemaker, 1997, International clinical psychopharmacology.

Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats.

D. Sanger, A. Jackson, 1989, The Journal of pharmacology and experimental therapeutics.

The actions of SCH 23390, a D1 receptor antagonist, on operant and avoidance behavior in rats

D. Sanger, 1987, Pharmacology, Biochemistry and Behavior.

Response decrement patterns after neuroleptic and non-neuroleptic drugs

D. Sanger, 2004, Psychopharmacology.

An analysis of the effects of systemically administered clonidine on the food and water intake of rats

D. Sanger, 1983, British journal of pharmacology.

The effects of caffeine on timing behaviour in rodents: Comparisons with chlordiazepoxide

D. Sanger, 2004, Psychopharmacology.

Study of the modulatory activity of bz (ω) receptor ligands on defensive behaviors in mice: Evaluation of the importance of intrinsic efficacy and receptor subtype selectivity

G. Perrault, D. Sanger, G. Griebel, 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The effects of pimozide and of reward omission on fixed-interval behavior of rats maintained by food and electrical brain stimulation

D. Sanger, A. Greenshaw, D. Blackman, 1981, Pharmacology Biochemistry and Behavior.

Neuroprotective effect of eliprodil: attenuation of a conditioned freezing deficit induced by traumatic injury of the right parietal cortex in the rat.

D. Sanger, P. Barnéoud, P. Moser, 1998, Journal of neurotrauma.

Lithium and alpha-methyl-p-tyrosine prevent "manic" activity in rodents.

D. Sanger, M. Tomkiewicz, D. U'prichard, 1974, Psychopharmacologia.

Ifenprodil and Eliprodil: Neuroprotective NMDA Receptor Antagonists and Calcium Channel Blockers

G. Perrault, D. Sanger, H. Schoemaker, 1997 .

THE BEHAVIOURAL PHARMACOLOGY OF SCHIZOPHRENIA

D. Sanger, P. Willner, A. Young, 2000 .

The Effects of Chlordiazepoxide on the Development of Adjunctive Drinking in Rats

D. Sanger, D. Blackman, 1975, The Quarterly journal of experimental psychology.

Animal Models for Assessing Anxiolytic, Neuroleptic, and Antidepressant Drug Action

D. Sanger, A. Greenshaw, T. Nguyễn, 1988 .

Effects of chronic treatment with triazolam on operant responding in rats

D. Sanger, C. Cohen, 1994, Pharmacology Biochemistry and Behavior.

The effects of tranquillizing drugs on timing behaviour in rats

D. Sanger, D. Blackman, 1975, Psychopharmacologia.

Differential effects of chlordiazepoxide and d-amphetamine on responding maintained by a DRL schedule of reinforcement

M. Key, D. Sanger, D. Blackman, 2004, Psychopharmacologia.

Behavioral pharmacology in the era of neuroscience.

D. Sanger, J. Barrett, 1991, Journal of the experimental analysis of behavior.

The effects of clozapine on shuttle-box avoidance responding in rats: Comparisons with haloperidol and chlordiazepoxide

D. Sanger, 1985, Pharmacology Biochemistry and Behavior.

Schedule-induced drinking and thirst: A pharmacological analysis

D. Sanger, P. K. Corfield-Sumner, 1979, Pharmacology Biochemistry and Behavior.

d-amphetamine and adjunctive drinking in rats

D. Sanger, 1977, Psychopharmacology.

New advances in the understanding and treatment of addiction.

D. Sanger, P. Willner, A. Young, 2002, Behavioural pharmacology.

The anti‐ischaemic drug, eliprodil, blocks hyperactivity induced by intra‐accumbens injection of spermine

G. Perrault, D. Sanger, E. Audi, 1995, Behavioural pharmacology.